Acasti Pharma (ACST) Q2 2023 Earnings

11AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.54
-0.39
-0.24
-0.09

Details

Expected EPS
-0.09
Actual EPS
-0.54
Surprise EPS
-0.45
Surprise Percent
+500%

Description

Acasti Pharma (ACST) has reported earnings of -0.54 per share for Q2 2023.

0 Comments

Share your thoughts